Dustin Sjuts
Plus aucun poste en cours
Fortune : 824 346 $ au 31/03/2024
Profil
Dustin S.
Sjuts worked as the Business Unit Head-China at Galderma Holding SA from 2017 to 2018.
He then served as the President at Revance Therapeutics, Inc. from 2021 to 2024.
Prior to his professional experience, he completed his undergraduate degree at Illinois State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2024 | 167 550 ( 0,16% ) | 824 346 $ | 31/03/2024 |
Anciens postes connus de Dustin Sjuts
| Sociétés | Poste | Fin |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | President | 31/03/2024 |
Galderma Holding SA
 Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland. | Corporate Officer/Principal | 01/04/2018 |
Formation de Dustin Sjuts
| Illinois State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REVANCE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Galderma Holding SA
Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland. | Health Technology |
